期刊
EXPERIMENTAL DERMATOLOGY
卷 22, 期 2, 页码 98-101出版社
WILEY
DOI: 10.1111/exd.12075
关键词
11-HSD1; 11-HSD2; basal cell carcinoma; proliferation; seborrhoeic keratosis; squamous cell carcinoma
类别
资金
- Japan Society for the Promotion of Science [24659529]
- Cosmetology Research Foundation
- Grants-in-Aid for Scientific Research [24689045, 24659529] Funding Source: KAKEN
The enzyme 11-hydroxysteroid dehydrogenase (11-HSD) catalyzes the interconversion between hormonally active cortisol and inactive cortisone within cells. There are two isozymes: 11-HSD1 activates cortisol from cortisone and 11-HSD2 inactivates cortisol to cortisone. 11-HSD1 was recently discovered in skin, and we subsequently found that the enzyme negatively regulates keratinocyte proliferation. We verified 11-HSD1 and 11-HSD2 expression in benign and malignant skin tumors and investigated the role of 11-HSD in skin tumor pathogenesis. Randomly selected formalin-fixed sections of skin lesions of seborrheic keratosis (SK), squamous cell carcinoma (SCC), and basal cell carcinoma (BCC) were stained with 11-HSD1 and 11-HSD2 antibodies, and 11-HSD expression was also evaluated in murine epidermis in which hyperproliferation was induced by 12-O-tetradecanoylphorbol-13 acetate (TPA). We observed that 11-HSD1 expression was decreased in all SK, SCC, and BCC lesions compared with unaffected skin. Conversely, 11-HSD2 expression was increased in SK and BCC but not in SCC. Overexpression of 11-HSD2 in keratinocytes increased cell proliferation. In the murine model, 11-HSD1 expression was decreased in TPA-treated hyperproliferative skin. Our findings suggest that 11-HSD1 expression is decreased in keratinocyte proliferative conditions, and 11-HSD2 expression is increased in basal cell proliferating conditions, such as BCC and SK. Assessing 11-HSD1 and 11-HSD2 expression could be a useful tool for diagnosing and characterizing skin tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据